CGON
CGON
NASDAQ · Biotechnology

Cg Oncology Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$69.62
+0.44 (+0.64%)
As of May 9, 1:20 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -48.4% upside
Low Target $23.54
Average Target $35.94
High Target $41.91
Current Price $69.62
Current
$69.62
Target
$35.94
$23.54 $35.94 avg $41.91
Scenario Analysis
Bear Case
$23.54
-66.2%
Low target
Base Case
$35.94
-48.4%
Avg target
Bull Case
$41.91
+-39.8%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$73.56
-5.4% from high
52-Week Low
$21.00
+231.5% from low
50-Day SMA
$47.74
+45.8% vs SMA
200-Day SMA
$36.07
+93.0% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$35.94
-51.1% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.59
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%